Influx Healthtech Ipo
Objects of the Issue
Funding capital expenditure requirements for setting up of manufacturing facility for Nutraceutical Division
Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division
Purchase of Machineries for Homecare and Cosmetic Division
General corporate purposes.
Influx Healthtech IPO Review
Canara Bank –
DRChoksey FinServ –
Emkay Global –
Hem Securities –
IDBI Capital –
Marwadi Shares –
Nirmal Bang –
SBICAP Securities –
Sharekhan –
SMC Global –
Sushil Finance –
Swastika Investmart –
Ventura Securities –
Geojit –
Reliance Securities –
Capital Market –
BP Wealth –
ICICIdirect –
Choice Broking –
IPO Lead Managers aka Merchant Bankers
Rarever Financial Advisors Pvt. Ltd. Pvt. Ltd.
Application | Lot Size | Shares | Amount |
Retail Minimum | 1 | 1200 | ₹1,15,200 |
Retail Maximum | 1 | 1200 | ₹1,15,200 |
S-HNI Minimum | 2 | 2,400 | ₹2,30,400 |
IPO Open Date: | June 18, 2025 |
IPO Close Date: | June 20, 2025 |
Basis of Allotment: | June 23, 2025 |
Refunds: | June 24, 2025 |
Credit to Demat Account: | June 24, 2025 |
IPO Listing Date: | June 25, 2025 |
Period Ended | Revenue | Expense | Profit After Tax | Assets |
2023 | ₹76.06 | ₹66.32 | ₹7.20 | ₹28.30 |
2024 | ₹100.02 | ₹85.08 | ₹11.13 | ₹41.10 |
2025 | ₹104.99 | ₹87.11 | ₹13.37 | ₹70.30 |
KPI | Values |
ROE: | 36.98% |
ROCE: | 49.17% |
EBITDA Margin: | 19.62% |
PAT Margin: | 12.75% |
Debt to equity ratio: | 0.01 |
Earning Per Share (EPS): | ₹7.36 (Basic) |
Price/Earning P/E Ratio: | N/A |
Return on Net Worth (RoNW): | 36.98% |
Net Asset Value (NAV): | ₹19.91 |
Company | EPS | PE Ratio | RoNW % | NAV | Income |
Sudarshan Pharma Industries Limited | 0.66 | 48.28 | 12.45% | 5.30 | 505.38 Cr. |
Quest Laboratories Limited | 8.28 | 10.38 | 16.58% | 49.92 | 108.16 Cr. |
IPO Open Date: | June 18, 2025 |
IPO Close Date: | June 20, 2025 |
Face Value: | ₹10 Per Equity Share |
IPO Price Band: | ₹91 to ₹96 Per Share |
Issue Size: | Approx ₹58.57 Crores |
Fresh Issue: | Approx ₹48.00 Crores |
Offer for Sale: | Approx 11,00,400 Equity Shares |
Issue Type: | Book Build Issue |
IPO Listing: | NSE SME |
Retail Quota: | Not more than 35% |
QIB Quota: | Not more than 50% |
NII Quota: | Not more than 15% |
DRHP Draft Prospectus: | Click Here |
RHP Draft Prospectus: | Click Here |
Anchor Investors List: | Click Here |